home / stock / gild / gild articles

GILD Articles, Gilead Sciences Inc. - From 11/07/23

Stock Information
Company Name: Gilead Sciences Inc.
Stock Symbol: GILD
Market: NASDAQ
Website: gilead.com
Menu
GILD GILD Quote GILD Short GILD News GILD Articles GILD Message Board
Get GILD Alerts

News, Short Squeeze, Breakout and More Instantly...
Gilead Sciences Stock Slides After Hours On Q3 Report - Here's Why | Benzinga

Gilead Sciences, Inc. (NASDAQ: GILD) shares are volatile in Tuesday's after-hours session on the heels of the company's third-qua...
US Stocks Eye Longest Winning Streak In 2 Years, Oil Tumbles: What's Driving Markets Tuesday? | Benzinga

U.S. stocks are attempting to post the longest streak of consecutive positive sessions in over two years. As of midday trading in New York, both th...

Positive News For Gastric Cancers - Gilead/Arcus Biosciences' Combination Cancer Therapy Shows Encouraging Clinical Activity | Benzinga

Gilead Sciences Inc (NASDAQ: GILD) and Arcus Biosciences Inc (NYSE: RCUS) announced that domvanalimab plus zimberelimab and chemothe...

S&P 500, Nasdaq Set To Break 6-Day Rally Today? Traders Await Fed Cues, Analyst Says Seasonal Rally Has Started With Gusto | Benzinga

Sentiment appears to have dipped after a six-session winning streak. Stock futures indicate a modestly lower opening on Tuesday as small and mid-ca...
If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,200 Today | Benzinga

Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years by 5.88% on an annualized basis producing an average annual return...

Leidos Sees Robust Demand In Digital Modernization, Raises Annual Outlook | Benzinga

Leidos Holdings, Inc (NYSE: LDOS) reported third-quarter FY23 revenue growth of 9% year-over-year to $3.92 billion, beating the consensus of $...

Comparative Study: Gilead Sciences And Industry Competitors In Biotechnology Industry | Benzinga

Amidst the fast-paced and highly competitive business environment of today, conducting comprehensive company analysis is essential for investors an...
Pfizer Decides To Raise COVID-19 Treatment Pill Price, Defends Itself Amid Criticism for Cost Increase | Benzinga

Pfizer Inc (NYSE: PFE) is reportedly gearing up to price its Covid-19 drug Paxlovid at $1,390 for a five-day course, more than double what the...

Vertex Pharmaceuticals, Gilead Sciences And 2 Other Stocks Insiders Are Selling | Benzinga

The Nasdaq 100 closed lower by over 200 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell share...

Hepatitis-Focused Assembly Biosciences Stock Trading Over 100% Higher: Here's Why | Benzinga

Gilead Sciences Inc (NASDAQ: GILD) and Assembly Biosciences Inc (NASDAQ: ASMB) have entered into a 12-year partnership. Their goal i...
Previous 10 Next 10